Seeking Alpha

Wilbe

Wilbe
Send Message
View as an RSS Feed
View Wilbe's Comments BY TICKER:
Latest  |  Highest rated
  • Geron (GERN) has resumed trading after announcing it's discontinuing development of its GRN1005 brain cancer drug. Shares -12.2% AH to $1.30. [View news story]
    This company must be poorly led because this is the second or third thing they have terminated. I have lost quite a bit on this poorly run company.
    Dec 3 08:21 PM | Likes Like |Link to Comment
  • Apple: One More Thing [View article]
    Why does anyone listen to the blow-hard? He is full of himself and is as ususal inaccurate.
    Sep 14 02:46 AM | Likes Like |Link to Comment
COMMENTS STATS
2 Comments
0 Likes